Source: European Biotechnology

NorthSea Therapeutics: NorthSea Therapeutics completes US$80m Series C financing

Read full article »
NorthSea Therapeutics's Competitors | NorthSea Therapeutics's News | NorthSea Therapeutics's Financials
Stay up-to-date with the latest news on NorthSea Therapeutics
Est. Annual Revenue
$100K-5.0M
Est. Employees
25-100
Rob De Ree's photo - CEO of NorthSea Therapeutics

CEO

Rob De Ree

CEO Approval Rating

90/100

Read more
Stay up-to-date with the latest news on NorthSea Therapeutics